Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 663 in its research report dated June 28, 2023.

Neutral Zydus LifeSciences; target of Rs 550: Motilal Oswal

Motilal Oswal recommended Neutral rating on Zydus LifeSciences with a target price of Rs 550 in its research report dated May 18, 2023.

Accumulate Zydus Lifesciences; target of Rs 520: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Zydus Lifesciences with a target price of Rs 520 in its research report dated May 18, 2023.

Zydus Lifesciences: Time to book profit, post strong rally over a year?

Management is aiming for a single-digit growth in the US market for FY24 on the back of launches from the Moraiya facility.

Buy Zydus Lifesciences; target of Rs 572: Sharekhan

Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 572 in its research report dated March 21, 2023.

Accumulate Zydus Lifesciences; target of Rs 480: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Zydus Lifesciences with a target price of Rs 480 in its research report dated February 06, 2023.

Buy Zydus Lifesciences; target of Rs 572: Sharekhan

Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 572 in its research report dated February 03, 2023.

Buy Zydus Lifesciences; target of Rs 500: ICICI Direct

ICICI Direct is bullish on Zydus Lifesciences recommended buy rating on the stock with a target price of Rs 500 in its research report dated February 04, 2023.

Zydus Lifesciences: Transdermal opportunity to unfold

The US and domestic formulation businesses help the pharma company to do well in Q3

Buy Zydus Lifesciences; target of Rs 563: Sharekhan

Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 563 in its research report dated January 12, 2023.

Pharma: Is the pandemic investment template about to play out?

The return of the flu season in India and the US, and COVID-19 in China sparked more investor interest in the sector.

Hold Zydus Lifesciences; target of Rs 480: ICICI Direct

ICICI Direct recommended hold rating on Zydus Lifesciences with a target price of Rs 480 in its research report dated November 14, 2022.

Accumulate Zydus Lifesciences; target of Rs 465: Prabhudas Lilladher

Prabhudas Lilladher recommended accumulate rating on Zydus Lifesciences with a target price of Rs 465 in its research report dated November 14, 2022.

Hold Zydus Lifesciences: target of Rs 405: ICICI Direct

ICICI Direct recommended hold rating on Zydus Lifesciences with a target price of Rs 405 in its research report dated August 13, 2022.

Buy Zydus Lifesciences; target of Rs 425: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 425 in its research report dated August 11, 2022.

Buy Zydus Lifesciences; target of Rs 440: Sharekhan

Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 440 in its research report dated August 10, 2022.

Zydus Lifesciences: Nephrology, biosimilar scope takes focus

Valuation reasonable on the back of traction in branded business

Buy Zydus Lifesciences; target of Rs 445: KR Choksey

KR Choksey is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 445 in its research report dated May 25, 2022.

Buy Zydus Lifesciences; target of Rs 450: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 450 in its research report dated May 23, 2022.

Buy Zydus LifeSciences; target of Rs 420: Motilal Oswal

Motilal Oswal is bullish on Zydus LifeSciences recommended buy rating on the stock with a target price of Rs 420 in its research report dated May 21, 2022.

Buy Zydus Lifesciences: target of Rs 440: Sharekhan

Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 440 in its research report dated May 20, 2022.

Buy Zydus Lifesciences: target of Rs 480: Sharekhan

Sharekhan is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 480 in its research report dated April 07, 2022.

Accumulate Cadila Healthcare; target of Rs 445: KR Choksey

KR Choksey recommended accumulate rating on Cadila Healthcare with a target price of Rs 445 in its research report dated February 07, 2022.

Buy Cadila Healthcare; target of Rs 560: Sharekhan

Sharekhan is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 560 in its research report dated February 03, 2022.

Cadila: Biosimilars, oncology portfolio hold promise for medium term

The Moraiya plant’s pending USFDA approval is crucial for Cadila’s US ambition